Opportunity Information: Apply for HT942526MRPSRA
Apply for HT942526MRPSRA
- The Defense Health Agency Contracting Activity - DHACA in the science and technology and other research and development sector is offering a public funding opportunity titled "DoW Melanoma Research Program Survivorship Research Award" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 12.420.
- This funding opportunity was created on 2026-05-21.
- Applicants must submit their applications by 2026-10-14. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 2 candidate(s).
- Eligible applicants include: Unrestricted.
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY26 Department of Defense Melanoma Research Program (MRP) Survivorship Research Award (Funding Opportunity Number HT942526MRPSRA) is a discretionary grant opportunity run through the Defense Health Agency Contracting Activity (DHACA) under CFDA 12.420. It is designed to push forward melanoma-specific survivorship research, an area the announcement describes as relatively new and historically underfunded. The program is looking for research that can make a meaningful, near-term difference in the day-to-day health and well-being of people who have survived melanoma, as well as benefits for their families and care partners.
A core theme of this award is that survivorship is not treated as “survival time†alone. Projects must address quality of life, overall health, and/or functional outcomes in a way that is directly relevant to melanoma survivors. Applications that focus exclusively on animal models are explicitly considered non-responsive, and proposals that only measure survival without integrating quality-of-life, health, or functional considerations also do not fit the intent of the award. In practical terms, the program is signaling that it wants patient-centered, real-world survivorship outcomes rather than purely preclinical work or studies that stop at mortality endpoints.
One of the defining requirements is the expectation of genuine consumer involvement. Every application must include at least one melanoma consumer collaborator, meaning a melanoma survivor, a family member, and/or a care partner who contributes lived-experience expertise to the project team. As an alternative, an applicant can partner with a melanoma-community supporting organization that meaningfully supports the planning, execution, and implementation of the research. This requirement is meant to ensure the research stays grounded in survivor realities and that study design, recruitment approaches, outcome selection, and dissemination plans reflect the needs and priorities of the melanoma community.
The opportunity allows clinical trials, which broadens the range of eligible projects to include interventional studies testing survivorship-focused strategies in people. That could include interventions aimed at improving physical functioning, mental health, symptom burden, long-term treatment effects, return-to-work outcomes, caregiver strain, or other survivorship challenges, as long as the work is innovative, impactful, and oriented toward near-term improvements.
Eligibility is listed as unrestricted, meaning a wide range of applicant organizations may apply, consistent with typical DoD research programs (for example, academic institutions, nonprofits, for-profits, and other research entities, depending on standard federal grant rules). The original application closing date is October 14, 2026, and the posting indicates an expectation of two awards. The award ceiling is not specified in the provided listing, so applicants would need to consult the full announcement or related program guidance for budget limits and other financial constraints.
Overall, this funding opportunity is best understood as a call for translational, patient-centered melanoma survivorship research that is shaped with direct input from survivors and/or the organizations that support them, with an emphasis on outcomes that matter to daily life and long-term well-being, not just disease-free or overall survival.
FY26 DoD Melanoma Research Program (MRP) Survivorship Research Award (HT942526MRPSRA) - FAQs
What is this funding opportunity?
This opportunity is the FY26 Department of Defense (DoD) Melanoma Research Program (MRP) Survivorship Research Award. The Funding Opportunity Number is HT942526MRPSRA, and it is administered through the Defense Health Agency Contracting Activity (DHACA) under CFDA 12.420.
What is the main goal of the Survivorship Research Award?
The main goal is to advance melanoma-specific survivorship research that can make a meaningful, near-term difference in the day-to-day health and well-being of melanoma survivors, and also provide benefits for their families and care partners. The announcement frames survivorship research as relatively new and historically underfunded, and this award is meant to help move the field forward.
How does this award define "survivorship"?
Survivorship is not treated as survival time alone. Projects are expected to address quality of life, overall health, and/or functional outcomes that are directly relevant to melanoma survivors, rather than focusing only on whether someone lives longer.
What types of outcomes does the program want researchers to study?
The program emphasizes patient-centered, real-world survivorship outcomes. Projects should focus on outcomes that matter to daily life and long-term well-being, such as quality of life, overall health, and functional outcomes, as long as they are directly relevant to melanoma survivors.
Are applications that only measure survival considered responsive?
No. Proposals that only measure survival without integrating quality-of-life, health, or functional considerations do not fit the intent of this award.
Are animal-only studies allowed under this award?
No. Applications that focus exclusively on animal models are explicitly considered non-responsive for this award.
Does the award support clinical trials?
Yes. The opportunity allows clinical trials, which means applicants may propose interventional studies that test survivorship-focused strategies in people, as long as the work is innovative, impactful, and oriented toward near-term improvements in survivorship-related outcomes.
What kinds of survivorship-focused interventions might fit the intent of this award?
The listing indicates that interventions could target survivorship challenges such as physical functioning, mental health, symptom burden, long-term treatment effects, return-to-work outcomes, caregiver strain, or other melanoma survivorship needs. The key is that the study is melanoma-specific and focused on outcomes that improve day-to-day life and well-being.
What is the consumer involvement requirement?
Every application must include genuine consumer involvement. At least one melanoma consumer collaborator is required. A consumer collaborator can be a melanoma survivor, a family member, and/or a care partner who contributes lived-experience expertise to the project team.
Is there an alternative to including an individual consumer collaborator?
Yes. As an alternative, an applicant can partner with a melanoma-community supporting organization that meaningfully supports the planning, execution, and implementation of the research.
Why does the program require consumer involvement?
The intent is to keep the research grounded in real survivor experiences and priorities. The requirement is meant to influence practical aspects of the project such as study design, recruitment approaches, selection of outcomes, and dissemination plans so they align with the needs of the melanoma community.
Who is eligible to apply?
Eligibility is listed as unrestricted. This generally means a wide range of applicant organizations may apply, consistent with standard federal grant rules. Examples can include academic institutions, nonprofits, for-profits, and other research entities, depending on the normal requirements that apply to federal discretionary grants.
When is the application due?
The original application closing date listed is October 14, 2026.
How many awards does the program expect to make?
The posting indicates an expectation of two awards.
What is the maximum award amount (award ceiling)?
The award ceiling is not specified in the information provided. Applicants would need to consult the full announcement or related program guidance for budget limits and any other financial constraints.
What makes a proposal a good fit for this opportunity?
Based on the description provided, a strong fit would be translational, patient-centered melanoma survivorship research shaped with direct input from melanoma survivors and/or organizations that support the melanoma community, with an emphasis on near-term, practical improvements in quality of life, health, and functional outcomes (not just survival endpoints).
Browse more opportunities from the same category: Science and Technology and other Research and Development
Next opportunity: DoW Prostate Cancer, Early Investigator Research Award
Previous opportunity: Rural Opioid Technical Assistance Centers
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for HT942526MRPSRA
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (HT942526MRPSRA) also looked into and applied for these:
| Funding Opportunity |
|---|
| DoW Melanoma Research Program Idea Award Apply for HT942526MRPIA Funding Number: HT942526MRPIA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Melanoma Research Program Team Science Award Apply for HT942526MRPTSA Funding Number: HT942526MRPTSA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Military Burn, Discovery Award Apply for HT942526MBRPDA Funding Number: HT942526MBRPDA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Prostate Cancer, Idea Development Award Apply for HT942526PCRPIDA Funding Number: HT942526PCRPIDA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Prostate Cancer, Early Investigator Research Award Apply for HT942526PCRPEIRA Funding Number: HT942526PCRPEIRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Prostate Cancer, Physician Research Award Apply for HT942526PCRPPRA Funding Number: HT942526PCRPPRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Prostate Cancer, Data Science Award Apply for HT942526PCRPDSA Funding Number: HT942526PCRPDSA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Traumatic Brain Injury and Psychological Health, Health Services Research Award Apply for HT942526TBIPHRPHSRA Funding Number: HT942526TBIPHRPHSRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Traumatic Brain Injury and Psychological Health, Translational Research Award Apply for HT942526TBIPHRPTRA Funding Number: HT942526TBIPHRPTRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Toxic Exposures Clinical Trial Award Apply for HT942526TERPCTA Funding Number: HT942526TERPCTA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Toxic Exposures Translational Research Award Apply for HT942526TERPTRA Funding Number: HT942526TERPTRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Toxic Exposures Investigator Initiated Research Award Apply for HT942526TERPIIRA Funding Number: HT942526TERPIIRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| FY 2026 Competitive Academic Agreement Program (CAAP) Apply for 693JK326NF0003 Funding Number: 693JK326NF0003 Agency: Pipeline and Hazardous Materials Safety Admin Category: Science and Technology and other Research and Development Funding Amount: $1,000,000 |
| Solutions for Energy Security A U.S. India Energy Technology Partnership Apply for OFOP0002859 Funding Number: OFOP0002859 Agency: U.S. Mission to India Category: Science and Technology and other Research and Development Funding Amount: $300,000 |
| DoW Epilepsy Idea Development Award Apply for HT942526ERPIDA Funding Number: HT942526ERPIDA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Epilepsy Leveraging Research Award Apply for HT942526ERPLRA Funding Number: HT942526ERPLRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Epilepsy Virtual Post-Traumatic Epilepsy Research Center – Leadership Award Apply for HT942526ERPVPTERCL Funding Number: HT942526ERPVPTERCL Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Orthopaedic, Clinical Research Award Apply for HT942526ORPCRA Funding Number: HT942526ORPCRA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Epilepsy Research Partnership Award Apply for HT942526ERPRPA Funding Number: HT942526ERPRPA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
| DoW Orthopaedic, Applied Research Award Apply for HT942526ORPARA Funding Number: HT942526ORPARA Agency: Defense Health Agency Contracting Activity - DHACA Category: Science and Technology and other Research and Development Funding Amount: Case Dependent |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants

Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "HT942526MRPSRA", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.
